Janarthan Y Nikhil

  • Citations Per Year
Learn More
BACKGROUND The Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) trial compared the use of eptifibatide with placebo in 2064 coronary intervention(More)
  • 1